TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MicroTech Medical (Hangzhou) Co., Ltd. Class H ( (HK:2235) ) has issued an announcement.
MicroTech Medical (Hangzhou) Co., Ltd. has announced a change in the utilization of its remaining unutilized proceeds from its Global Offering and an extension of the expected timetable for their use. The company plans to fully utilize the funds by December 31, 2027, to further develop its core product through clinical trials, expand its global commercialization capabilities, and enhance its manufacturing capacity. This strategic move is expected to strengthen the company’s market position and operational capabilities.
The most recent analyst rating on (HK:2235) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on MicroTech Medical (Hangzhou) Co., Ltd. Class H stock, see the HK:2235 Stock Forecast page.
More about MicroTech Medical (Hangzhou) Co., Ltd. Class H
MicroTech Medical (Hangzhou) Co., Ltd. is a company based in China, specializing in medical technology. The company focuses on developing and commercializing medical products, particularly in the area of diabetes management. It aims to expand its market presence globally through clinical trials, registration in major markets, and enhancing its commercialization capabilities.
Average Trading Volume: 327,717
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.81B
See more data about 2235 stock on TipRanks’ Stock Analysis page.